 |
Pneuma Respiratory
Last updated: September 15, 2024
Eric Hunter, CEO
USA | Funding: $23.3M (+)
Website: https://pneumarespiratory.com/
Pneuma Respiratory is focused on creating therapeutic treatments for diseases of the lungs using a digital first platform for inhaled drug delivery. Our focus is to improve the potential effectiveness of currently available and novel drugs, with the initial targets being approved therapeutics for asthma and COPD.
Website: https://pneumarespiratory.com/
Pneuma Respiratory is focused on creating therapeutic treatments for diseases of the lungs using a digital first platform for inhaled drug delivery. Our focus is to improve the potential effectiveness of currently available and novel drugs, with the initial targets being approved therapeutics for asthma and COPD.
